🟢 ProMIS Neurosciences is trading 5% up in pre-market with no clear company-specific catalyst identified

ProMIS Neurosciences is trading at $3.59, up 5.28% in November 4 pre-market, with no clear company-specific catalyst identified.

• The November 12 earnings and business update was announced November 3, but does not establish the reason for the gain.
• Broader futures were modestly higher, but available evidence does not link that backdrop to the stock’s move.
• The prior session closed at $3.41 after rising 13.67%. Trading volume and pre-market activity details were unavailable.